23.34

3.63% 0.7576

Dyne Therapeutics Inc (DYN)

Overview News Price History Option Chain Financials Why DYN Down? Discussions Forecast

Dyne Therapeutics Inc stock is traded at $23.34, with a volume of 1.49M. It is up +3.63% in the last 24 hours and up +79.17% over the past month. Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Previous Close:

$22.58

Open:

$22.5

24h Volume:

1.49M

Relative Volume:

0.54

Market Cap:

$3.33B

Revenue:

Net Income/Loss:

$-412.89M

P/E Ratio:

-6.046

EPS:

-3.86

Net Cash Flow:

$-361.93M

1W Performance:

-3.19%

1M Performance:

+79.17%

6M Performance:

+97.30%

1Y Performance:

-18.58%

1-Day Range:

$21.77

$23.42

1-Week Range:

$21.77

$25.00

52-Week Range:

$6.36

$35.68

Dyne Therapeutics Inc Stock (DYN) Company Profile

Name

Dyne Therapeutics Inc

Sector

Healthcare (1139)

Industry

Biotechnology (635)

Phone

(781) 786-8230

Address

1560 TRAPELO ROAD, WALTHAM

Employee

206

Twitter

Next Earnings Date

2024-11-04

Latest SEC Filings

DYN's Discussions on Twitter

Compare DYN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DYN Dyne Therapeutics Inc	23.42	3.21B	0	-412.89M	-361.93M	-3.86
VRTX Vertex Pharmaceuticals Inc	424.52	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.42	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	431.79	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	822.21	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	184.05	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-10-25	Downgrade	Oppenheimer	Outperform → Perform
Aug-25-25	Upgrade	Raymond James	Outperform → Strong Buy
Jun-24-25	Initiated	Bernstein	Mkt Perform
Jun-11-25	Resumed	Raymond James	Outperform
Jun-02-25	Resumed	Oppenheimer	Outperform
May-29-25	Initiated	Evercore ISI	Outperform
Mar-12-25	Initiated	BMO Capital Markets	Outperform
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Dec-13-24	Initiated	Robert W. Baird	Outperform
Nov-26-24	Initiated	RBC Capital Mkts	Outperform
Oct-24-24	Downgrade	JP Morgan	Overweight → Neutral
May-21-24	Reiterated	Chardan Capital Markets	Buy
Apr-30-24	Initiated	Morgan Stanley	Overweight
Feb-20-24	Initiated	H.C. Wainwright	Buy
Feb-27-23	Upgrade	Raymond James	Outperform → Strong Buy
Feb-15-23	Initiated	Oppenheimer	Outperform
Jan-26-23	Initiated	Guggenheim	Buy
Jul-20-22	Initiated	Chardan Capital Markets	Buy
Jul-12-22	Initiated	Raymond James	Outperform
Oct-12-20	Initiated	JP Morgan	Overweight
Oct-12-20	Initiated	Jefferies	Buy
Oct-12-20	Initiated	Piper Sandler	Overweight
Oct-12-20	Initiated	Stifel	Buy

View All

Dyne Therapeutics Inc Stock (DYN) Latest News

10:13 AM

Assessing Dyne Therapeutics (DYN) Valuation Following Recent Share Price Rally - Yahoo Finance

10:13 AM

10:01 AM

Dyne Therapeutics Inc. stock volume spike explainedProfit Target & Daily Technical Forecast Reports - newser.com

10:01 AM

08:51 AM

Analyzing Dyne Therapeutics Inc. with risk reward ratio chartsQuarterly Trade Report & Safe Entry Momentum Tips - newser.com

08:51 AM

08:42 AM

Will Dyne Therapeutics Inc. stock go up soonPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com

08:42 AM

07:36 AM

Dyne Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

07:36 AM

07:30 AM

Dyne Therapeutics (Nasdaq: DYN) to present at four investor conferences; webcasts available - Stock Titan

07:30 AM

06:25 AM

What recovery options are there for Dyne Therapeutics Inc.2025 Growth vs Value & Weekly Watchlist for Hot Stocks - newser.com

06:25 AM

05:35 AM

Can you recover from losses in Dyne Therapeutics Inc.Market Movement Recap & AI Driven Price Forecasts - newser.com

05:35 AM

03:40 AM

Technical analysis overview for Dyne Therapeutics Inc. stockWeekly Risk Report & Weekly Stock Performance Updates - newser.com

03:40 AM

01:00 AM

Using RSI to spot recovery in Dyne Therapeutics Inc.2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com

01:00 AM

12:04 PM

Will Dyne Therapeutics Inc. stock deliver better than expected guidance2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com

12:04 PM

Nov 02, 2025

Why Dyne Therapeutics Inc. stock is seen as undervalued2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com

Nov 02, 2025

Historical volatility pattern of Dyne Therapeutics Inc. visualizedJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com

Nov 02, 2025

Sector ETF performance correlation with Dyne Therapeutics Inc.2025 Price Momentum & Smart Money Movement Tracker - newser.com

Nov 02, 2025

Nov 01, 2025

Can trapped investors hope for a rebound in Dyne Therapeutics Inc.July 2025 Opening Moves & Fast Moving Trade Plans - newser.com

Nov 01, 2025

Dyne Therapeutics Inc.’s volatility index tracking explainedRate Hike & Low Drawdown Investment Strategies - newser.com

Nov 01, 2025

Is Dyne Therapeutics Inc. stock entering bullish territory2025 Top Gainers & Reliable Volume Spike Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Is Dyne Therapeutics Inc. reversing from oversold territoryPortfolio Value Summary & Fast Exit and Entry Strategy Plans - newser.com

Oct 31, 2025